Recent Articles from GlobeNewswire

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CLEVELAND, Ohio, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4).
By Abeona Therapeutics Inc. · Via GlobeNewswire · October 2, 2026
InflaRx to Present Late-Breaking Pre-clinical Data on Izicopan at Kidney Week 2026
Jena, Germany, Oct. 02, 2026 (GLOBE NEWSWIRE) --  InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced that the Company has been selected for a late-breaking poster session at the American Society of Nephrology’s Kidney Week 2026, taking place in Denver, Colorado, USA, October 21 - 25.
By InflaRx N.V. · Via GlobeNewswire · October 2, 2026
Aura Minerals Announces Mining Fleet Insourcing at Apoena, Almas and Borborema
ROAD TOWN, British Virgin Islands, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Aura Minerals Inc. ("Aura" or the "Company") (NASDAQ: AUGO | B3: AURA33) announced today that it has signed a definitive agreement to acquire a company (“Newco”) that will hold the mining fleet, related equipment leases and dedicated workforce currently operated by a third-party contractor in three of its gold operations in Brazil — Apoena, Almas and Borborema — and to bring fleet operation and maintenance in-house (the "Insourcing"), with the transition targeted for January 2027. At MSG, the Company already operates the mine fleet directly.
By Aura Minerals Inc · Via GlobeNewswire · October 2, 2026
Pyxis Oncology Announces Closing of Up to $282.6 Million Public Offering
BOSTON, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS or the “Company”), a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, today announced that it closed its previously announced registered public offering (the "Offering") on October 1, 2026. The Offering generated approximately $110.0 million in upfront gross proceeds, before deducting underwriting discounts and commissions and other offering expenses. The Offering consisted of 36,047,919 shares of common stock at a public offering price of $2.90 per share and, in lieu of common stock to certain investors, pre-funded warrants to purchase 1,883,121 shares of common stock at a public offering price of $2.899 per pre-funded warrant, in each case, accompanied by common warrants to purchase an aggregate of 49,310,352 shares of common stock.
By Pyxis Oncology · Via GlobeNewswire · October 2, 2026
CoinShares Appoints Matt Morris as Chief Financial Officer as Company Enters Next Phase as a U.S.-Listed Company
Appointment reflects planned succession following Nasdaq listing and further strengthens CoinShares' U.S. public-company finance capabilities; Richard Nash, CFO since 2019, to remain with CoinShares, ensuring continuity through the transitionJERSEY, Channel Islands - October 1, 2026 - CoinShares PLC (Nasdaq: CSHR) (“CoinShares” or the “Company”), a leading global asset manager specializing in digital assets, today announced the appointment of Matt Morris as Chief Financial Officer, effective immediately.Mr. Morris succeeds Richard Nash, who has served as Chief Financial Officer of the CoinShares group since 2019 and will remain with the Company as a senior member of the CEO Office, supporting the Group on strategic initiatives and ensuring continuity through the transition. The appointment of Mr. Morris completes a planned succession process initiated in connection with CoinShares' transition to the U.S. public markets and further strengthens the Company's financial leadership as it enters its next phase of growth as a Nasdaq-listed company.Mr. Morris is already deeply embedded within CoinShares' finance organization. He has worked continuously with the Company since August 2025, initially as Managing Director at Centri Business Consulting, where he led the advisory engagement supporting CoinShares' U.S. listing and transition to U.S. public-company reporting, and since August 2026 as Deputy Chief Financial Officer.During that period, Mr. Morris worked alongside Mr. Nash and the CoinShares finance team through the Company's transition from IFRS to U.S. GAAP, the establishment of its U.S. public-company reporting infrastructure and its Nasdaq listing. His appointment therefore provides continuity of leadership while adding extensive U.S. public-company finance, reporting and control experience to the executive team.Jean-Marie Mognetti, Co-Founder, President and Chief Executive Officer of CoinShares, said: “This appointment is the culmination of a succession process we began well before our listing in New York and represents another important step in the evolution of CoinShares as a U.S.-listed company.Matt comes into the role already knowing our business, our numbers, our systems and, importantly, our people. He worked alongside Richard and our finance team throughout one of the most significant transformations in our history, including our transition to U.S. GAAP and the preparation for our Nasdaq listing.What Matt brings to the role is the combination we were looking for: continuity with the finance organization we have built, together with extensive experience helping companies operate successfully within the U.S. public markets. As CoinShares enters its next phase, we believe his appointment further strengthens the financial discipline, reporting infrastructure and execution capabilities of the Company.Richard has made an exceptional contribution to CoinShares. During his tenure as CFO, we completed three public listings, transformed our financial reporting infrastructure and developed the finance organization that supports CoinShares today. I am particularly pleased that Richard will remain with the Company as a senior member of the CEO Office, allowing us to retain his experience and institutional knowledge while ensuring a seamless transition.”An Experienced U.S. Public-Company Finance ExecutiveMr. Morris brings more than fourteen years of experience across public-company accounting, financial reporting, capital markets transactions and internal controls.Prior to joining CoinShares, he held senior roles at Centri Business Consulting and Ernst & Young LLP, where he advised public companies and management teams on complex accounting and reporting matters, public listings, capital markets transactions, acquisitions and integrations, accounting conversions and internal control over financial reporting.Earlier in his career, Mr. Morris audited public and private companies at PricewaterhouseCoopers LLP. He is a U.S. Certified Public Accountant and is based in the United States.As Chief Financial Officer, Mr. Morris will oversee CoinShares' global finance organization, financial reporting and SEC filings, financial planning and analysis, treasury and capital management, internal financial controls and investor-facing financial communications. He will serve as the Company's principal financial officer and report directly to the Chief Executive Officer.Mr. Morris said: “Having worked closely with CoinShares and its finance team throughout the Company's transition to the U.S. public markets, I have had the opportunity to understand both the strength of the platform that Richard and the team have built and the opportunity ahead of us.CoinShares has a strong balance sheet, an established global business and an ambitious strategy for its next phase of growth. I am excited to take on the role of CFO and to work with Jean-Marie, Richard and the wider leadership team as we continue building the financial infrastructure and discipline required to support that ambition as a U.S.-listed company.”Continued Leadership from Richard NashMr. Nash has served as Chief Financial Officer of the CoinShares group since 2019 and has overseen a period of significant transformation for the Company, including its listing on Nasdaq Stockholm in 2021, its transition to the U.S. GAAP and PCAOB reporting requirements, and its subsequent listing in the United States.As a senior member of the CEO Office, Mr. Nash will support the Group on strategic initiatives and the transition of the CFO responsibilities. His continued involvement enables CoinShares to retain the institutional knowledge and experience accumulated during his seven years as CFO.Mr Nash said: “It has been a privilege to serve as CFO through such an important period in CoinShares' development. Matt has worked closely with the finance team throughout our transition to the U.S. public markets and understands both the organization and the reporting environment exceptionally well. I look forward to continuing to support Matt, Jean-Marie and the Company in my new role.”Third-Quarter 2026 Results CallCoinShares expects to report its third-quarter 2026 results in November 2026. Mr. Morris will lead the third-quarter financial reporting process and participate in the Company's results call. The Company will provide further details regarding the results call and how investors may join this call closer to the date thereof.Forward-Looking StatementsThis press release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. These forward-looking statements include, without limitation, statements regarding the Chief Financial Officer transition, Richard Nash’s continuing role with the Company, the expected benefits of the leadership transition, CoinShares’ future growth and strategic priorities, and other statements identified by words such as “believes,” “expects,” “intends,” “may,” “plans,” “will,” and similar expressions.These statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to differ materially from those expressed or implied by such forward-looking statements. Additional risk factors are described in the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2025, and in the Company’s other filings and submissions with the U.S. Securities and Exchange Commission.CoinShares undertakes no obligation to update or revise any forward-looking statements to reflect events or circumstances occurring after the date of this press release, except as required by applicable law.About CoinSharesCoinShares is a leading global asset manager specializing in digital assets that delivers a broad range of financial services across investment management, trading and securities to a wide array of clients that includes corporations, financial institutions and individuals. Focusing on crypto since 2013, the firm is headquartered in Jersey, with offices in France, Sweden, Switzerland, the UK and the US. CoinShares is regulated in Jersey by the Jersey Financial Services Commission, in France by the Autorité des marchés financiers, and in the US by the Securities and Exchange Commission, National Futures Association and Financial Industry Regulatory Authority. CoinShares is publicly listed on Nasdaq under the ticker CSHR.Investor Relations | investor.coinshares.com | corporateir@coinshares.com 
By CoinShares PLC · Via GlobeNewswire · October 1, 2026
CECO Environmental to Transfer U.S. Stock Exchange Listing to the Texas Stock Exchange
Common stock expected to begin trading on TXSE on October 19, 2026, under existing ticker symbol “CECO”
By CECO Environmental Corp. · Via GlobeNewswire · October 2, 2026
Nova Capital Management Acquires BMP Group of Companies and RB Medical from Andrew Industries
London and Chicago, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Nova Capital Management (“Nova”), a private equity firm focused on acquiring and growing industrial and specialized manufacturing businesses, today announced the acquisition of the BMP Group of companies and RB Medical from Andrew Industries. Terms of the transaction were not disclosed.
By Nova Capital Management USA LLC · Via GlobeNewswire · October 2, 2026
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a transformative pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases, today announced that on October 1, 2026, the Company granted (i) non-qualified stock options to one newly-hired non-executive employee to purchase a total of 62,900 shares of the Company’s common stock at an exercise price per share of $2.30, which was the closing price per share of the Company’s common stock as reported by NASDAQ on October 1, 2026, and (ii) restricted stock units (RSUs) representing 72,700 shares of its common stock to two newly-hired non-executive employees, including the newly-hired employee receiving the non-qualified stock options referenced above. The grants were approved by the Compensation Committee of the Company’s Board of Directors and granted under the Company’s Amended and Restated Inducement Equity Plan as an inducement material to the new employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4). The options will vest over four years, with 25% of the shares underlying the option vesting on the one-year anniversary of the grant date and the remaining 75% vesting in approximately equal monthly installments over the following thirty-six months, subject to the employee being continuously employed by the Company through each vesting date. The RSUs will vest over four years, with 25% of the shares underlying each RSU award vesting on each anniversary of the grant date, subject to the employees being continuously employed by the Company through each vesting date.
By Fate Therapeutics, Inc. · Via GlobeNewswire · October 2, 2026
Walden Biosciences to Present Phase 1+ and Phase 2 Data for WAL0921 at American Society of Nephrology Kidney Week
Late-breaking poster presentation to showcase initial activity of WAL0921 in proteinuric kidney diseaseAdditional poster demonstrates WAL0921 is safe, well tolerated, and reduces circulating suPAR levels in healthy participants
Workable Launches Native WhatsApp Integration, Helping Recruiters Reach Candidates Where They Actually Respond
BOSTON, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Workable, the leading recruiting and HR software platform for growing businesses, announced native WhatsApp integration, a new capability that lets recruiters send and receive WhatsApp messages with candidates directly from within Workable. Every conversation is stored automatically alongside the candidate's emails, notes, and evaluations, giving hiring teams one record of every interaction instead of a thread trapped in a separate app.
By Workable · Via GlobeNewswire · October 2, 2026
Digbi Health Unifies Metabolic, Inflammatory and Hormonal Care on One Precision Biology Telehealth Platform
Employers can now deliver GLP-1 and hormone replacement therapy through a unified care team, without layering on another standalone point solution
By Digbi Health · Via GlobeNewswire · October 2, 2026
Transaction in Own Shares
Transaction in Own Shares
By Shell plc · Via GlobeNewswire · October 2, 2026
Silvaco CEO Dr. Walden “Wally” Rhines Inducted into the National Academy of Engineering
Prestigious honor recognizes co-invention of the blue-light-emitting diode and a lifetime of leadership in the semiconductor industry
By Silvaco · Via GlobeNewswire · October 2, 2026
Addex Therapeutics Announces Executive Management Changes
Ad Hoc Announcement Pursuant to Art. 53 LR
By Addex Therapeutics · Via GlobeNewswire · October 2, 2026
ISS enters into new partnership with Tryg
ISS, a global leader in workplace experience and facility services, has signed a new eight-year contract with Tryg, the leading non-life insurer in Scandinavia. The contract covers Denmark, Norway and Sweden and has an annual value of approximately DKK 100 million.
By ISS World Services A/S · Via GlobeNewswire · October 2, 2026
Ending MS Is Within Reach: National MS Society Raises a Record-Breaking $12 Million to Launch the Campaign to End MS
Nearly 500 guests gathered at Cipriani 42nd Street for the Campaign to End MS Gala, emceed by Ginger Zee and honoring David Osmond and his family, as the Society kicked off its five-year, $1 billion campaign
New Drug Application Submission Initiated for Zipalertinib Plus Chemotherapy in First-Line EGFR Exon 20 Insertion Mutation NSCLC for Review Under FDA Real-Time Oncology Review Program
In the Phase 3 REZILIENT3 study, zipalertinib combination therapy demonstrated longest median progression-free survival observed to date in first-line EGFR exon20ins NSCLC 
By Cullinan Therapeutics, Inc. · Via GlobeNewswire · October 1, 2026
Nouryon brings U.S. solar project online at Morris, Illinois, facility
Global specialty chemicals leader Nouryon today announced it has started generating solar power at its manufacturing plant in Morris, Ill., the company’s first solar project in the U.S. Developed in partnership with local energy provider Convergent Energy and Power, the installation supplies electricity directly to the site, advancing the company’s plans to use more electricity from renewable and low-carbon sources across its global operations. Nouryon expects the system to generate about 3,400 megawatt-hours of electricity a year, enough to cover about 10% of the site’s electricity needs and avoid an estimated 1,152 metric tons of greenhouse gas emissions annually.
By Nouryon · Via GlobeNewswire · October 1, 2026
Medicenna Announces Results of Annual General and Special Meeting of Shareholders
TORONTO and HOUSTON, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQB: MDNAF), a clinical-stage immunotherapy company developing Superkines for targeting cancer and autoimmune diseases, today announced the voting results from the Company’s annual general and special meeting of shareholders held today, October 1, 2026 (the “Meeting”).
By Medicenna Therapeutics Corp. · Via GlobeNewswire · October 1, 2026
Wandercraft Acquires Ekso Bionics, Uniting Two Pioneers to Advance and Expand Robotic Mobility
End-to-end continuum of care, powered by medical exoskeletons, an expanded global clinical network, and trailblazing R&D capabilities, expands options for upright mobility, from rehabilitation to everyday life
By Wandercraft · Via GlobeNewswire · October 1, 2026
Exodus Brings Stablecoins to Everyday Commerce, Starting With DIRECTV’s DGO
Exodus Checkout, a new merchant payments product for accepting stablecoins, launches in Argentina and expands across Latin America
By Exodus · Via GlobeNewswire · October 1, 2026
Carbon Streaming Sells 100% of the Community Carbon Stream and Inventory of Carbon Credits for US$6,000,000
TORONTO, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Carbon Streaming Corporation (Cboe CA: NETZ) (OTCID: OFSTF) (FSE: M2Q) (“Carbon Streaming” or the “Company”) has entered into an agreement with Community Carbon and UpEnergy Group (collectively, the “UPE Parties”) pursuant to which the Company will receive total consideration of US$6.0 million in connection with the termination of the Community Carbon Stream and transfer of the Company’s remaining portfolio of carbon credits, with a portion of the consideration funded through the sale of certain CORSIA-tagged Tanzanian cookstove carbon credits to a third-party purchaser.
By Carbon Streaming Corporation · Via GlobeNewswire · October 1, 2026
Small Caps Test Their 200-Day Line as Yields Grind Higher and Earnings Season Stirs
SAN FRANCISCO, Oct. 01, 2026 (GLOBE NEWSWIRE) -- USA Newsroom News Commentary - This has been a week of slow leaks rather than blowouts for U.S. stocks. As of midday Thursday, the Dow Jones Industrial Average, the S&P 500, the Nasdaq Composite and the Russell 2000 were all lower for the week, with small caps taking the hardest hit as the 10-year Treasury yield climbed 6 basis points on the week to 5.24%, according to the latest edition of The Roadmap from Stock Preachers. At the same time, a fresh batch of company results is starting to show which businesses are protecting their margins in a tougher cost environment. Active companies with developments this week include: McCormick & Company, Incorporated (NYSE: MKC), Conagra Brands, Inc. (NYSE: CAG), WTW (Nasdaq: WTW), RedHill Biopharma Ltd. (Nasdaq: RDHL), and Recon Technology, Ltd (Nasdaq: RCON).
By USA Newsroom · Via GlobeNewswire · October 1, 2026
A21 to Premiere Seen, New Short Film Addressing Online Child Sexual Exploitation, at Global Freedom Summit
Annual global awareness event will bring communities together to understand the evolving threat of online child sexual exploitation and learn practical ways to help protect children.
By A21 · Via GlobeNewswire · October 1, 2026
UWM Holdings Corporation Investors Have Until October 13th to Contact Bragar Eagel & Squire, P.C. Seeking Lead Plaintiff Role
Bragar Eagel & Squire, P.C. Litigation Partners Brandon Walker and Melissa Fortunato Encourage Investors Who Suffered Losses In UWM To Contact Them Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · October 1, 2026
Phillips Edison & Company Reaffirms Full Year 2026 Earnings Guidance; Increases Full Year 2026 Gross Acquisitions Guidance; Provides Investment Update
CINCINNATI, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Phillips Edison & Company, Inc. (Nasdaq: PECO) (“PECO”), one of the nation’s largest owners and operators of high-quality, grocery-anchored neighborhood shopping centers, today provided an update on full year 2026 investment activity, reaffirmed 2026 earnings guidance and updated 2026 acquisitions guidance.
By Phillips Edison & Company, Inc. · Via GlobeNewswire · October 1, 2026
Phillips Edison & Company Announces $377.5 Million Expansion of Joint Venture with Northwestern Mutual
Expansion Recognizes the Strength of PECO’s Operating Platform while Generating Capital for PECO to Acquire Properties with Strong Growth Profiles
By Phillips Edison & Company, Inc. · Via GlobeNewswire · October 1, 2026
Mohawk Industries, Inc. Invites You to Join its Third Quarter Earnings Conference Call
CALHOUN, Ga., Oct. 01, 2026 (GLOBE NEWSWIRE) --  In conjunction with Mohawk Industries’ (NYSE: MHK) Third Quarter 2026 earnings release on Thursday, October 29, 2026, you are invited to listen to the conference call that will be broadcast live on Friday, October 30, 2026, at 11:00 am ET.
By Mohawk Industries, Inc. · Via GlobeNewswire · October 1, 2026
Algoma Steel Group Inc. Provides Guidance for the Third Quarter 2026
SAULT STE. MARIE, Ontario, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Algoma Steel Group Inc. (NASDAQ: ASTL; TSX: ASTL) (“Algoma” or “the Company”), a leading Canadian producer of steel plate and hot rolled sheet products, today provided guidance for its quarter ended September 30, 2026. Unless otherwise specified, all amounts are in Canadian dollars.
By Algoma Steel Inc · Via GlobeNewswire · October 1, 2026
Bragar Eagel & Squire, P.C. Urges Fractyl Health, Inc. Stockholders with Large Losses to Contact the Firm Before October 20th
If you purchased or acquired Fractyl securities between January 13, 2025 and January 29, 2026 and would like to discuss your legal rights, contact Bragar Eagel & Squire partners Brandon Walker or Melissa Fortunato by email at investigations@bespc.com or by telephone at (212) 355-4648.
By Bragar Eagel & Squire · Via GlobeNewswire · October 1, 2026
A Landmark Flight, Culinary Festivals and Endless Summer: October in The Bahamas
Island Spotlight: Ragged Island
By The Bahamas Ministry of Tourism · Via GlobeNewswire · October 1, 2026
Axogen Completes Acquisition of BioCircuit Technologies, Adding NerveTape™, the First FDA Cleared Device for Sutureless Peripheral Nerve Repair
ALACHUA, Fla. and TAMPA, Fla., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (“Axogen” or the “Company”) (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced that it has completed its previously announced acquisition of BioCircuit Technologies, Inc. (“BioCircuit”), a privately held medical device company and developer of NerveTape™.
By Axogen, Inc. · Via GlobeNewswire · October 1, 2026
Bragar Eagel & Squire, P.C. Urgently Reminds Pentair plc Investors to Contact the Firm Seeking Lead Plaintiff Role Before October 2nd
Bragar Eagel & Squire, P.C. Litigation Partners Brandon Walker and Melissa Fortunato Encourage Investors Who Suffered Losses In Pentair (PNR) To Contact Them Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · October 1, 2026
Ero Copper to Release Third Quarter 2026 Operating and Financial Results on November 2, 2026
VANCOUVER, British Columbia, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Ero Copper Corp. (TSX: ERO, NYSE: ERO) ("Ero" or the “Company”) will publish its third quarter 2026 operating and financial results on Monday, November 2, 2026, after market close. The Company will host a conference call to discuss the results on Tuesday, November 3, 2026 at 10:30 a.m. Eastern Time. A results presentation will be available for download via the webcast link and in the Presentations section of the Company's website on the day of the conference call.
By Ero Copper Corp. · Via GlobeNewswire · October 1, 2026
Osisko Gold Announces Management Update
TORONTO, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Osisko Gold Group Inc. (NYSE: OGG, TSXV: OGG) ("Osisko Gold" or the "Company") announces that, further to its August 25, 2026, announcement regarding the Company's planned leadership succession transition, Elijah Tyshynski has assumed the role of Chief Financial Officer of the Company effective October 1, 2026, succeeding Alexander Dann.
By Osisko Gold Group Inc. · Via GlobeNewswire · October 1, 2026
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NEW YORK and WALTHAM, Mass., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the treatment of severe autoimmune diseases, today announced that it granted equity awards on October 1, 2026, to six newly-hired, non-executive employees. The inducement grants were approved by the Company's independent Compensation Committee and were made as material inducements to acceptance of employment with Dianthus in accordance with Nasdaq Listing Rule 5635(c)(4).
By Dianthus Therapeutics, Inc. · Via GlobeNewswire · October 1, 2026
Westlake Royal Building Products™ Enters Standing-Seam Roofing Market Through Purchase of Roofing Assets
HOUSTON, Oct. 01, 2026 (GLOBE NEWSWIRE) -- A subsidiary of Westlake Royal Building Products™, which is owned by Westlake Corporation (NYSE and NYSE Texas: WLK), announced today that it has completed a transaction to acquire specified metal roofing assets, including facilities in Albuquerque, New Mexico; Wichita Falls, Texas; and Hutchins, Texas, from Metal Center, Inc.
By Westlake Royal Building Products · Via GlobeNewswire · October 1, 2026
STACK Infrastructure Achieves SBTi Validation of Science-Based Net-Zero Targets
Independent validation confirms the rigor, transparency, and accountability of STACK’s pathway to net-zero by 2050
By STACK Infrastructure, Inc. · Via GlobeNewswire · October 1, 2026
KBR Appoints Rami Qasem to Board of Directors
HOUSTON, Oct. 01, 2026 (GLOBE NEWSWIRE) -- KBR (NYSE: KBR) announced today the appointment of Rami Qasem to its board of directors effective October 1, 2026.
By Kellogg Brown & Root LLC. · Via GlobeNewswire · October 1, 2026
Guggenheim Investments Announces October 2026 Closed-End Fund Distributions
NEW YORK, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Guggenheim Investments today announced that certain closed-end funds have declared their distributions. The table below summarizes the distribution schedule for each closed-end fund (collectively, the “Funds” and each, a “Fund”).
onsemi and Synaptics Announce Revised Merger Agreement
Revised Terms to Deliver Higher onsemi Shareholder Value through Immediate EPS Accretion 
By onsemi · Via GlobeNewswire · October 1, 2026
Service Ventures Invests in Fias to Launch AI Development and Monetization Platform
Service Credit Union and Fias have partnered to launch a highly secure AI application marketplace platform, where anyone can easily create, deploy and monetize applications, and where end users keep all their applications, data and agents in one easily expandible, blockchain-supported location.
By Service Credit Union · Via GlobeNewswire · October 1, 2026
Sagimet Biosciences Announces Closing of Underwritten Offering of Series A Common Stock and Pre-Funded Warrants
FOSTER CITY, Calif., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced the closing of its previously announced underwritten offering of 8,750,010 shares of its Series A common stock at a price of $10.00 per share, or for certain investors that so chose, in lieu of shares of Series A common stock, pre-funded warrants to purchase 2,750,010 shares of its Series A common stock (the “Pre-Funded Warrants”) at a price of $9.9999 per Pre-Funded Warrant. The Pre-Funded Warrants have an exercise price of $0.0001 per share and are exercisable immediately. The gross proceeds from the offering were approximately $115.0 million, before deducting underwriting discounts and commissions and other offering expenses. All of the securities in the offering were sold by Sagimet.
By Sagimet Biosciences Inc. · Via GlobeNewswire · October 1, 2026
National Healthcare Properties Announces Fourth Quarter 2026 Common Stock Dividend
NEW YORK, Oct. 01, 2026 (GLOBE NEWSWIRE) -- National Healthcare Properties, Inc. (Nasdaq: NHP) (the “Company”) announced today that its Board of Directors declared a quarterly dividend of $0.075 per share of its common stock (including its Class A Common Stock). The dividend will be payable in cash on October 16, 2026 to holders of record at the close of business on October 12, 2026.
By National Healthcare Properties · Via GlobeNewswire · October 1, 2026
Verisk to Announce Fiscal Third-Quarter 2026 Results on November 5, 2026
JERSEY CITY, N.J., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Verisk (Nasdaq: VRSK), a leading strategic data analytics and technology partner to the global insurance industry, will report its financial results for the fiscal third quarter ended September 30, 2026, on Thursday, November 5, 2026, before the market open. The press release, with accompanying financial information, will be posted on the Verisk investor website at http://investor.verisk.com.
By Verisk Analytics, Inc. · Via GlobeNewswire · October 1, 2026
Axis Capital to Release Third Quarter Financial Results on October 28, 2026
PEMBROKE, Bermuda, Oct. 01, 2026 (GLOBE NEWSWIRE) --  AXIS Capital Holdings Limited (“AXIS Capital” or the “Company”) (NYSE: AXS) today announced that it expects to release financial results for the third quarter ended September 30, 2026 on Wednesday, October 28, 2026 after the close of the financial markets.
By AXIS Capital Holdings Limited · Via GlobeNewswire · October 1, 2026
Enact Mortgage Insurance Enters Into a Forward Quota Share Reinsurance Transaction as Part of its Diversified Credit Risk Transfer Program
Secures approximately 35% of quota share reinsurance coverage from a panel of third-party reinsurance providers
By Enact Holdings, Inc. · Via GlobeNewswire · October 1, 2026
Occidental to Announce Third Quarter Results Monday, November 9, 2026; Hold Conference Call Tuesday, November 10, 2026
HOUSTON, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Occidental (NYSE: OXY) will announce its third quarter 2026 financial results after close of market on Monday, November 9, 2026, and will hold a conference call to discuss the results on Tuesday, November 10, 2026, at 1 p.m. Eastern/12 p.m. Central.
By Occidental · Via GlobeNewswire · October 1, 2026
ESCO Completes Acquisition of Megger Group Limited
St. Louis, Oct. 01, 2026 (GLOBE NEWSWIRE) -- ESCO Technologies Inc. (NYSE: ESE) today announced that it has completed the acquisition of the Megger Group Limited (Megger) business of TBG AG (TBG). Under the terms of the transaction, TBG has agreed to certain lock-up provisions with respect to its equity ownership in ESCO common stock and has nomination rights for one seat on ESCO’s Board of Directors. 
By ESCO Technologies Inc. · Via GlobeNewswire · October 1, 2026
ADARx Pharmaceuticals Announces the Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares Granted in Its Initial Public Offering
SAN DIEGO, Oct. 01, 2026 (GLOBE NEWSWIRE) -- ADARx Pharmaceuticals, Inc. (ADARx) (Nasdaq: ADRX), a late-stage clinical biotechnology company developing next-generation siRNA therapeutics, announced today that, in connection with its upsized initial public offering of its common stock, the underwriters have fully exercised their option to purchase an additional 3,937,500 shares of ADARx’s common stock at a price to the public of $17.00 per share. The issuance of the additional shares closed on October 1, 2026, bringing the total number of shares sold in the initial public offering to 30,187,500 shares and the aggregate gross proceeds to ADARx from the offering, before deducting underwriting discounts and commissions and offering expenses payable by ADARx, to approximately $513.2 million.
By ADARx Pharmaceuticals Inc. · Via GlobeNewswire · October 1, 2026
Elevra Lithium Provides Ewoyaa Sale Update
BRISBANE, Australia, Oct. 01, 2026 (GLOBE NEWSWIRE) -- North American lithium producer Elevra Lithium Limited (“Elevra”) (ASX:ELV; NASDAQ:ELVR) provides an update on the proposed sale of its interests in the Ewoyaa Lithium Project (“Ewoyaa Project”) in Ghana to Zhejiang Huayou Cobalt Co., Ltd. (“Huayou”) where the Ghanaian Government approval process continues and Huayou has received FIRB approval for the proposed acquisition of Atlantic Lithium Limited (“Atlantic Lithium”).
By Elevra Lithium Limited · Via GlobeNewswire · October 1, 2026
Yesway Completes Iowa and Kansas Portfolio Sale to Redeploy Capital into Higher-Return Growth Opportunities
Divestiture of non-strategic assets supports a stronger balance sheet and investment in new-to-industry stores in faster-growing core markets
By Yesway, Inc. · Via GlobeNewswire · October 1, 2026
Slide to Report 2026 Third Quarter Earnings Results on October 27, 2026
TAMPA, Fla., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Slide Insurance Holdings, Inc. (“Slide”) (Nasdaq: SLDE) announced today it will release its 2026 third quarter financial results on Tuesday, October 27, 2026, after the market closes. The Company will host a conference call and live webcast on Wednesday, October 28, 2026, at 8:30 AM Eastern time.
By Slide Insurance Holdings, Inc. · Via GlobeNewswire · October 1, 2026
NANOBIOTIX Announces the Appointment of Arnd Christ as Chief Financial Officer
PARIS and CAMBRIDGE, Mass., Oct. 01, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO - NASDAQ: NBTX - the “Company”), a late-stage clinical biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer and other major diseases, today announced the appointment of Arnd Christ as chief financial officer and member of the Company’s executive board, effective October 1, 2026. Mr. Christ brings more than two decades of financial leadership in publicly listed biotechnology companies in Europe and the United States. He succeeds Bart Van Rhijn, who will step down as chief financial & business officer and member of the executive board after five years of service to the Company.
By Nanobiotix S.A. · Via GlobeNewswire · October 1, 2026
Starling Oncology Leadership Highlights Recent and Upcoming Industry Conference Participation
Physician leaders share clinical insights on value-based therapy delivery, clinical trial access and integrated behavioral health in community oncology at major industry forums
By Starling Oncology · Via GlobeNewswire · October 1, 2026
ENDAVA CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Endava plc and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Endava (DAVA) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · October 1, 2026
Rent-A-Center/Acima Leasing/Brigit Data Breach: Ademi LLP Investigates Claims for Possible Damages Suffered by Customers
MILWAUKEE, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Ademi LLP is investigating potential data privacy claims arising from a data breach involving lease to own company Upbound Group, Inc. (NASDAQ: UPBD), which operates as Rent-a-Center/Acima Leasing and Brigit. We are investigating whether Unbound maintained reasonable safeguards to protect personal information.
By Ademi LLP · Via GlobeNewswire · October 1, 2026
WISeSat.Space Holdings Corp. Announces Closing of Business Combination with Columbus Acquisition Corp.
GENEVA, Switzerland, October 1, 2026 -- WISeSat.Space Holdings Corp., a British Virgin Islands business company (“Pubco” or “WISeSat”), today announced the completion today October 1, 2026 (“Closing”) of its previously announced business combination with Columbus Acquisition Corp (“CAC”) (the “Business Combination”). The ordinary shares of Pubco, the combined company following the Business Combination, will commence trading on the Nasdaq on October 2, 2026, under the ticker symbol “SAIQ.”
By WISeSat.Space Corp · Via GlobeNewswire · October 1, 2026
WISeKey’s Redomiciliation from Switzerland to the British Virgin Islands Becomes Legally Effective
Zug, Switzerland, October 1, 2026 – WISeQey Corp. (formerly known as WISeKey International Corp., “WISeQey” or the “Company”) (SIX: WIHN; NASDAQ: WKEY), a leading global quantum cybersecurity and space IoT company, today announced that the previously announced redomiciliation of WISeKey International Holding Ltd (“WISeKey”) from Switzerland to the British Virgin Islands became legally effective today (the “Redomiciliation”). The Redomiciliation was implemented through a cross-border merger of WISeKey with and into WISeQey, its wholly owned British Virgin Islands subsidiary, with WISeQey as the surviving company (the “Merger”).
AsiaStrategy Signs Memorandum of Understanding with Plume Network to Advance Real-World Asset Tokenisation Across Asia
Non-binding memorandum contemplates a joint venture pairing Plume’s tokenisation infrastructure with AsiaStrategy’s and Sora Ventures’ distribution across Asia, positioning the Company for what it believes will be a structural shift in how financial assets are issued, held, and traded
By AsiaStrategy · Via GlobeNewswire · October 1, 2026
Trasteel Holding S.A. and Sizzle Acquisition Corp. II Announce Confidential Submission of Draft Registration Statement on Form F-4 in Connection with the Proposed Business Combination
LUGANO, Switzerland and BERTRANGE, Luxembourg, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Trasteel Holding S.A. (“Trasteel” or the “Company”), a global steel trading and industrial group headquartered in Lugano (Switzerland) and Luxembourg, and Sizzle Acquisition Corp. II (Nasdaq: SZZL) (“Sizzle II”), a publicly traded special purpose acquisition company, today announced that Trasteel S.A. (“Pubco”), a newly formed Luxembourg holding company, confidentially submitted a draft registration statement on Form F-4 (as amended from time to time, the “Registration Statement”) to the U.S. Securities and Exchange Commission (the “SEC”) on September 30, 2026. The Registration Statement relates to the previously announced business combination agreement, dated as of April 13, 2026, as amended (the “Business Combination Agreement”), by and among Sizzle II, Trasteel, Pubco and the parties thereto. 
By Sizzle Acquisition Corp. II · Via GlobeNewswire · October 1, 2026
Resmed to Report First Quarter Fiscal 2027 Earnings on October 29, 2026
SAN DIEGO, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2027 on Thursday, October 29, 2026, after the New York Stock Exchange closes. Following the release, Resmed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast.
By Resmed, Inc. · Via GlobeNewswire · October 1, 2026
Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NEEDHAM, Mass., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal immunotherapies to improve disease outcomes for patients with cancer, today announced that on September 30, 2026, the Compensation Committee of Candel’s Board of Directors (the Board) granted to 4 new employees, stock options to purchase an aggregate of 85,900 shares of the Company’s common stock, with a per share exercise price of $10.44.
By Candel Therapeutics · Via GlobeNewswire · October 1, 2026
Nutriband Marks Five Years on Nasdaq – CEO Letter to Shareholders
Nutriband CEO Gareth Sheridan Congratulates Shareholders on Five-Year Nasdaq Listing Anniversary
By Nutriband Inc. · Via GlobeNewswire · October 1, 2026
Digital Realty Schedules Third Quarter 2026 Earnings Release and Conference Call
AUSTIN, Texas, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Digital Realty (NYSE: DLR), the world’s largest cloud- and carrier-neutral data center platform, today announced that it will release financial results for the third quarter of 2026 after the market closes on Thursday, October 29, 2026. The company will host a conference call to discuss these results at 5:00 p.m. ET / 4:00 p.m. CT on Thursday, October 29, 2026. 
By Digital Realty Trust, L.P. · Via GlobeNewswire · October 1, 2026
Robinhood Markets, Inc. to Announce Third Quarter 2026 Results on October 27, 2026
MENLO PARK, Calif., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Today, Robinhood Markets, Inc. (“Robinhood”) (NASDAQ: HOOD) announced that it will release its third quarter 2026 financial results on Tuesday, October 27, 2026, after market close. Robinhood will host a video call with Chairman & Chief Executive Officer Vlad Tenev and Chief Financial Officer Shiv Verma to discuss its results at 2:00 PM PT / 5:00 PM ET on the same day. The video call and supporting materials will be available at investors.robinhood.com. The event will also be live streamed to YouTube and X.com via Robinhood’s official channels, @RobinhoodApp, and within the Robinhood mobile app. Following the call, a replay and transcript will be available at investors.robinhood.com.
By Robinhood Markets, Inc. · Via GlobeNewswire · October 1, 2026
Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Fluence Energy, Inc. and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Fluence (FLNC) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · October 1, 2026
Healthy Moms, Healthy Babies America (HMHBA) Announces $20 Million in State Grants for Arkansas and Kentucky
$10 million to each state over 5 years will help bring proven maternal health solutions to more rural communities
Arvinas to Present Novel Biomarker Data from the Phase 1 Clinical Trial for ARV-102, a PROTAC LRRK2 Degrader, at the 2026 International Congress of Parkinson’s Disease and Movement Disorders®
NEW HAVEN, Conn., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that novel biomarker data from a Phase 1 clinical trial of ARV-102 in participants with Parkinson’s disease will be presented as late-breaking oral and poster presentations at the 2026 International Congress of Parkinson’s Disease and Movement Disorders® (MDS), taking place October 4-8, 2026, in Seoul, Korea.
By Arvinas Inc. · Via GlobeNewswire · October 1, 2026
Replimune Announces TUDRIQEV™ Now Available in the U.S. for Advanced Melanoma
ReplimuneConnect Plus a comprehensive program that provides dedicated support and resources to help eligible patients access TUDRIQEV in the U.S. now live
By Replimune, Inc. · Via GlobeNewswire · October 1, 2026
Bank OZK Announces Increase to Quarterly Common Stock Dividend and Announces Preferred Stock Dividend
Sixty-five consecutive quarters of quarterly common stock dividend increases
By Bank OZK · Via GlobeNewswire · October 1, 2026
Bragar Eagel & Squire, P.C. is Investigating Medline Inc. on Behalf of Medline Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Medline (MDLN) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · October 1, 2026
American Indian College Fund Partners with Tribal Colleges and Universities to Support Native Voter Registration
Nine TCUs Receive Micro-Grants to Encourage Participation in Midterm Elections
By American Indian College Fund · Via GlobeNewswire · October 1, 2026
Recor Medical Announces AMA CPT Editorial Panel Approval of Two New Category I CPT® Codes for Renal Denervation
New Category I CPT codes represent an important milestone toward standardized reporting and broader access to the Paradise™ Ultrasound Renal Denervation System for the treatment of patients with uncontrolled hypertension.
By Recor Medical · Via GlobeNewswire · October 1, 2026
reVolver Podcasts’ Erazno y La Chokolata and Código Vital Named Among 2026’s Best Podcasts
Two reVolver Podcasts programs named Signal Award finalists in the Comedy and Health & Wellness categories; fans can vote for the Listener’s Choice Award through October 15
By reVolver Podcasts · Via GlobeNewswire · October 1, 2026
Articles from GlobeNewswire | WAOW